CRANBURY, N.J., June 03, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced upcoming presentations at the following scientific and investor conferences in June.

Upcoming Scientific Conference:

• Michael C. Diem, MD, Senior Vice President of Business and Corporate Development, will present at the 2019 BIO International Convention in Philadelphia, PA on Tuesday, June 4, 2019 at 2:45 p.m. ET.

Upcoming Investor Conferences:

• Daphne Quimi, Chief Financial Officer, will present a corporate overview at the Jefferies 2019 Healthcare Conference in New York, NY on Friday, June 7, 2019 at 8:00 a.m. ET.
   
• John F. Crowley, Chairman and Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 40^th Annual Global Healthcare Conference in Ranchos Palos Verdes, CA on Wednesday, June 12, 2019 at 8:00 a.m. PT.

A live audio webcast of the Jefferies 2019 Healthcare Conference and Goldman Sachs 40^th Annual Global Healthcare Conference presentations can be accessed via the Investors section of the Amicus Therapeutics corporate website at http://ir.amicusrx.com/events-and-presentations, and will be archived for 90 days.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on Twitter and LinkedIn.

CONTACTS:

Investors/Media:
Amicus Therapeutics
Sara Pellegrino, IRC
Vice President, Investor Relations & Corporate Communications
spellegrino@amicusrx.com
(609) 662-5044

Media:
Amicus Therapeutics
Marco Winkler
mwinkler@amicusrx.com
(609) 662-2798

FOLD–G

Source: Amicus Therapeutics, Inc.